CTRI/2020/06/025763
Completed
Phase 2
A Randomized controlled Clinical Trial to determine the complementary effect of selected Siddha formulations in facilitating the possibility of accelerated recovery in COVID 19 patients. - SIDCOVID
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Sponsor
- ational institute of Siddha
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male, Female and Transgenders.
- •ï?· Age between 18 to 85 years
- •ï?· COVID 19 positive asymptomatic / pre symptomatic, mild and moderately and severely symptomatic patients.
- •ï?· Willing to consent to the study.
Exclusion Criteria
- •High risk groups (Patients with Complications of Diabetes, Heart diseases, Cancer and Pregnancy)
- •ï?· Multi organ failure Syndrome (MODS).
- •ï?· Patients participating in other COVID 19 trials.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Optimized TacrolimuS and MMF for HLA Antibodies (proteins that are sometimes produced by the immune system) after Renal TransplantatioRenal Transplant recipients with HLA antibodies, who are at increased risk of graft dysfunction and graft failureMedDRA version: 14.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 100000004865Therapeutic area: Body processes [G] - Immune system processes [G12]EUCTR2012-004308-36-GBKings College London
Completed
Not Applicable
Evaluation of the safety and initial performance of the REPAIR Bone Putty in the treatment of patients with tibia fracturesMusculoskeletal DiseasesOpen tibia fracturesPACTR201510001305535Carmell Therapeutics Corp.30
Recruiting
Phase 2
A Comparative Study to see the effect of Jatiphala Lepa( Myristica fragrans ) & Arjun Twak Lepa (Terminalia arjuna)in the management of Melasma.Health Condition 1: L814- Other melanin hyperpigmentationCTRI/2022/12/048415Dr Megha Champati Sawle
Not yet recruiting
Phase 2
To Study the effectiveness between Bilvadi Panchamoola Churna andGuduchyadi Churna in the management of Sthaulya [Overweight] in children of age group 8 to 15yearsHealth Condition 1: E663- OverweightCTRI/2023/11/060152Dr Pooja Mahadev Mukadam
Not yet recruiting
Phase 3
Drakshadi yoga in the management of Kaphaja KasaCTRI/2018/02/012160KAHER Shri B M K Ayurveda Mahavidyalaya